BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6244668)

  • 1. [Metabolism and kinetics of ampicillin elimination in cirrhosis. Therapeutical consequences (author's transl)].
    Chalas J; Labayle D; Macarrio J; Barraud D; Lindenbaum A; Buffet C; Chaput JC
    Sem Hop; 1980 Mar 8-15; 56(9-10):464-9. PubMed ID: 6244668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolism and kinetics of ampicillin elimination in cirrhosis. Therapeutical consequences. (author's transl)].
    Chalas J; Labayle D; Macarrio J; Barraud D; Lindenbaum A; Buffet C; Chaput JC
    Pathol Biol (Paris); 1979 Sep; 27(7):411-6. PubMed ID: 388320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of ascites on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Macias JG; Diez JL; Nieto MJ
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):57-61. PubMed ID: 7372376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ampicillin in cirrhosis.
    Lewis GP; Jusko WJ
    Clin Pharmacol Ther; 1975 Oct; 18(4):475-84. PubMed ID: 1164828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered kinetics of etozolin and its active metabolite ozolinone in hepatitis and hepatic cirrhosis with ascites.
    Knauf H; Missmahl M; Schölmerich J; Gerok W; Mutschler E
    Arzneimittelforschung; 1987 Dec; 37(12):1385-8. PubMed ID: 3449068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison between the pharmacokinetics of epicillin and ampicillin (author's transl)].
    Kienel G
    Arzneimittelforschung; 1976; 26(5):781-9. PubMed ID: 989351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamics of ascitic fluid in decompensated cirrhosis].
    Milani A; Mazzone M; Rossi L
    Recenti Prog Med; 1999 Feb; 90(2):94-9. PubMed ID: 10208100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of potassium ampicillin.
    Kaumeier S; Kisslinger E; Neiss A
    Arzneimittelforschung; 1980; 30(6):1019-21. PubMed ID: 7191262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compartmentalization of ascites and edema in patients with hepatic cirrhosis.
    Shear L; Ching S; Gabuzda GJ
    N Engl J Med; 1970 Jun; 282(25):1391-6. PubMed ID: 4910836
    [No Abstract]   [Full Text] [Related]  

  • 10. Bradykinin in the ascitic fluid of patients with liver cirrhosis.
    Cugno M; Salerno F; Nussberger J; Bottasso B; Lorenzano E; Agostoni A
    Clin Sci (Lond); 2001 Dec; 101(6):651-7. PubMed ID: 11724653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
    Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
    Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acid-base modifications induced by treatment with concentration-reinfusion of ascitis fluid in cyrrhosis (author's transl)].
    Novarini A; Guariglia A; Bruschi G; Borghi L; Canali M; Ghinelli F; Pasetti GC; Perinotto P
    Ateneo Parmense Acta Biomed; 1976; 47(1):5-13. PubMed ID: 1016272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of amikacin in ascitic cirrhotic patients].
    Vincent P; Izard D; Colombel JF; Husson MO; Cortot A; Paris JC; Leclerc H
    Therapie; 1985; 40(6):441-6. PubMed ID: 4089785
    [No Abstract]   [Full Text] [Related]  

  • 14. Ascitic fluid albumin and water flows in patients with alcoholic cirrhosis: effects of peritoneovenous shunting.
    Stanley MM; Belknap S; Biliack SA; Hartz CE; Houk JH
    J Lab Clin Med; 1994 Feb; 123(2):206-17. PubMed ID: 8301196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood.
    Nguyen-Khac E; Thevenot T; Capron D; Dharancy S; Paupart T; Thabut D; Tiry C
    Eur J Intern Med; 2008 Dec; 19(8):613-8. PubMed ID: 19046728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of cefoxitin in patients with ascites.
    Garcia MJ; Dominguez-Gil A; Perez FD; Rodriguez FP; Moronta FD
    Eur J Clin Pharmacol; 1981; 20(5):371-4. PubMed ID: 7286047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver (author's transl)].
    Rameis H; Bonelli J; Waginger H; Hruby K
    Wien Klin Wochenschr; 1981 Oct; 93(18):572-6. PubMed ID: 7303703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chylous ascites in cirrhotic and non-cirrhotic patients].
    Casafont F; López-Arias MJ; Crespo J; Dueñas C; Sánchez-Antolín G; Rivero M; Pons Romero F
    Gastroenterol Hepatol; 1997; 20(6):291-4. PubMed ID: 9296843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the transperitoneal passage of cefoxitin in the ascitic cirrhotic patient].
    Bourreille J; Le Bihan G; Beau B; Leroy A; Humbert G; Barthes PX
    Med Chir Dig; 1979; 8(7):667-70. PubMed ID: 537415
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood-liquor distribution of ampicillin in children with meningitis and without (author's transl)].
    Geering JM; Just M
    Arzneimittelforschung; 1975 Jul; 25(7):1085-8. PubMed ID: 1174414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.